DIAGNOS annonce l'inscription de ses actions ordinaires à la Bourse de Francfort
12 nov. 2024 09h00 HE
|
DIAGNOS inc.
BROSSARD, Québec, 12 nov. 2024 (GLOBE NEWSWIRE) -- Diagnos inc. (« DIAGNOS » ou la « Société ») (Bourse de croissance TSX : ADK, OTCQB : DGNOF, FWB : 4D4A), un pionnier dans la détection...
DIAGNOS Announces Cross-listing of its Common Shares on the Frankfurt Stock Exchange
12 nov. 2024 09h00 HE
|
DIAGNOS Inc.
BROSSARD, Quebec, Nov. 12, 2024 (GLOBE NEWSWIRE) -- Diagnos Inc. (“DIAGNOS” or the “Corporation”) (TSX Venture: ADK, OTCQB: DGNOF, FWB: 4D4A) a pioneer in early detection of critical health issues...
DIAGNOS Announces Closing of Private Placement
25 oct. 2024 15h45 HE
|
DIAGNOS Inc.
BROSSARD, Quebec, Oct. 25, 2024 (GLOBE NEWSWIRE) -- DIAGNOS Inc. (“DIAGNOS” or the “Corporation”) (TSX Venture: ADK) (OTCQB: DGNOF), a pioneer in early detection of critical health issues through...
DIAGNOS Announces the Engagement of Market Maker Consultant
17 oct. 2024 15h45 HE
|
DIAGNOS Inc.
BROSSARD, Quebec, Oct. 17, 2024 (GLOBE NEWSWIRE) -- Diagnos Inc. (“DIAGNOS” or the “Corporation”) (TSX Venture: ADK) (OTCQB: DGNOF), a pioneer in early detection of critical health issues through...
DIAGNOS Announces Grant of Stock Options
03 oct. 2024 15h30 HE
|
DIAGNOS Inc.
BROSSARD, Quebec, Oct. 03, 2024 (GLOBE NEWSWIRE) -- Diagnos Inc. ("DIAGNOS" or the "Corporation") (TSX Venture: ADK) (OTCQB: DGNOF), a pioneer in early detection of critical health issues through...
DIAGNOS Announces Voting Results of Meeting of Shareholders
26 sept. 2024 12h08 HE
|
DIAGNOS Inc.
BROSSARD, Quebec, Sept. 26, 2024 (GLOBE NEWSWIRE) -- DIAGNOS Inc. (“DIAGNOS” or the “Corporation”) (TSX Venture: ADK) (OTCQB: DGNOF), a pioneer in early detection of critical health issues through...
DIAGNOS Announces Variation in One Insider Ownership
23 sept. 2024 16h29 HE
|
DIAGNOS Inc.
BROSSARD, Quebec, Sept. 23, 2024 (GLOBE NEWSWIRE) -- In accordance with regulatory requirements, Diagnos Inc. (“DIAGNOS”, the “Corporation” or the “Issuer”) (TSX Venture: ADK), announces that as a...
DIAGNOS Announces Closing of Private Placement
20 sept. 2024 15h53 HE
|
DIAGNOS Inc.
BROSSARD, Quebec, Sept. 20, 2024 (GLOBE NEWSWIRE) -- DIAGNOS Inc. (“DIAGNOS” or the “Corporation”) (TSX Venture: ADK) (OTCQB: DGNOF), a pioneer in early detection of critical health issues through...
DIAGNOS annonce la date de l’assemblée générale et extraordinaire des actionnaires
22 août 2024 15h45 HE
|
DIAGNOS inc.
BROSSARD, Québec, 22 août 2024 (GLOBE NEWSWIRE) -- Diagnos inc. (« DIAGNOS » ou la « Société ») (Bourse de croissance TSX : ADK) (OTCQB : DGNOF), un pionnier dans la détection précoce de...
DIAGNOS Announces Date of Annual General and Special Meeting of Shareholders
22 août 2024 15h45 HE
|
DIAGNOS Inc.
BROSSARD, Quebec, Aug. 22, 2024 (GLOBE NEWSWIRE) -- Diagnos Inc. (“DIAGNOS” or the “Corporation”) (TSX Venture: ADK) (OTCQB: DGNOF) a leader in early detection of critical health issues through the...